Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Q
Not public, likely SF Bay Area, California, United Statesq.bio ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Q Bio’s Gemini platform enables rapid (15-min) full-body scans without radiation and creates a “digital twin” of a patient, integrating genetics, labs, and wearable data for population health management and risk prediction; strong partnership with Kaiser Permanente.
- Therapeutic areas
- Other
- Modalities
- DeviceAI-enabled diagnostic platformDigital twin modeling
- Industry
- Medical Imaging
02
Partnerships
Kaiser Foundation Hospitals (Kaiser Permanente)
Beyond the preview
Go deeper on Q.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Q.